Tanaka, Yoshiya http://orcid.org/0000-0002-0807-7139
Soen, Satoshi
Hirata, Shintaro
Okada, Yosuke
Fujiwara, Saeko
Tanaka, Ikuko
Kitajima, Yuriko
Kubota, Takuo
Ebina, Kosuke
Takashi, Yuichi
Inoue, Reiko
Yamauchi, Mika
Okubo, Naoaki
Ueno, Masanobu
Ohata, Yasuhisa
Ito, Nobuaki
Ozono, Keiichi
Nakayama, Hisanori
Terauchi, Masakazu
Tanaka, Sakae
Fukumoto, Seiji
Funding for this research was provided by:
Japanese Society for Bone and Mineral Research
Article History
Received: 16 September 2023
Accepted: 7 February 2024
First Online: 28 March 2024
Declarations
:
: IT, YK, RI, NO, MU, YO, NI, HN and SeF do not have conflict of interests to be disclosed.
: YoT has received speaker fees and/or honoraria from Eli Lilly, AstraZeneca, Abbvie, Asahi-Kasei, Gilead, Chugai, Behringer-Ingelheim, GlaxoSmithKline, Eisai, Taisho, Bristol-Myers, Pfizer, Taiho, received research grants from Asahi-Kasei, Mitsubishi-Tanabe, Eisai, Chugai, Taisho, SS has received speaker fees and/or honoraria from Amgen, Asahi Kasei Pharma, Astellas, Chugai, Daiichi-Sankyo, Eisai, Otsuka, Ono, Teijin Pharma, UCB Japan, SH has received speaker fee and/or honoraria from AbbVie, Asahi-Kasei Pharma, Astellas, AstraZeneca, Ayumi, Bristol Myers Squibb, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Eisai, Gilead Sciences, Glaxo SmithKline, Eli Lilly, Janssen, Novartis, Nippon Shinyaku, Pfizer, Taisho, Tanabe-Mitsubishi, UCB, received research grants from Asahi-Kasei Pharma, Eisai, Otsuka, Chugai, Eli Lilly, UCB, YO has received speaker fees and/or honoraria from Eli Lilly, SaF has received honoraria from Asahi-Kasei Pharma, and Teijin Healthcare, KE is affiliated with the Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, which is supported by Taisho. KE have received research grants from Abbvie, Asahi-Kasei, Astellas, Eisai, Mitsubishi-Tanabe, Ono, and Teijin Pharma and speaker fees and/or honoraria from Amgen, Asahi-Kasei, Astellas, Bristol-Myers, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Gilead, Mitsubishi-Tanabe, Ono, Pfizer, Taisho, and Teijin Pharma, YuT has received speaker fees and/or honoraria from Kyowa Kirin, TK has received honoraria from Eli Lilly and research grants from Teijin Pharma, Eli Lilly, MY has received speaker fees and/or honoraria from Asahi-Kasei, Daiichi-Sankyo and Teijin Pharma, KO has received speaker fees and/or honoraria from Kyowa Kirin, Alexion and Pfizer, MT received speaker fee and/or honoraria from Fuji, Otsuka, and Astellas, ST has received speaker fees and/or honoraria from Asahi-Kasei, Gilead, Daiichi-Sankyo, Amgen, and ID Pharma, received research grants from Chugai.